These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 526400)

  • 21. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
    Zech P; Pozet N; Sassard J; Vincent M
    Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of labetalol in hypertension during exercise and postural changes.
    Balasubramanian V; Mann S; Millar-Craig MW; Raftery EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):95S-100S. PubMed ID: 526410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypertension with labetalol.
    Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
    N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982; 12(10):729-35. PubMed ID: 7182212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment of hypertension with labetalol.
    Erichs M; Rothgardt NP; Andersson E
    Postgrad Med J; 1980; 56 Suppl 2():53-6. PubMed ID: 7433343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment of hypertension with labetalol.
    Prichard BN; Boakes AJ; Hernández R
    Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of labetalol on continuous ambulatory blood pressure.
    Balasubramanian V; Mann S; Raftery EB; Millar-Craig MW; Altman D
    Br J Clin Pharmacol; 1979; 8(Suppl 2):119S-123S. PubMed ID: 526391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
    Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
    Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral labetalol in the urgent treatment of severe hypertension.
    Olowoyeye JO; Okoro EO; Omotosho AB
    Trop Geogr Med; 1986 Mar; 38(1):73-8. PubMed ID: 3961913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.